Published in J Nucl Med on July 01, 1989
History of Chemistry in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Bull Hist Chem (2014) 0.77
Synthesis of 18F-6-FD. J Nucl Med (1990) 0.75
Stability of 6-[18F]fluorodopa preparations. J Nucl Med (1991) 0.75
Pfam 3.1: 1313 multiple alignments and profile HMMs match the majority of proteins. Nucleic Acids Res (1999) 11.64
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med (1994) 6.59
Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med (1990) 3.80
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A (1983) 3.39
The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature (2008) 3.02
Phosphatidylserine: selective enhancer of histamine release. Science (1971) 2.76
Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors. J Med Chem (1985) 2.52
Regulation of plasma membrane recycling by CFTR. Science (1992) 2.50
Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia. N Engl J Med (1990) 2.40
Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab (1993) 2.28
Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet (1999) 2.16
Functionalized congeners of adenosine: preparation of analogues with high affinity for A1-adenosine receptors. J Med Chem (1985) 2.12
CFTR chloride channel regulation by an interdomain interaction. Science (1999) 2.09
Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med (1996) 1.99
Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms. Nature (1997) 1.98
Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia. J Nucl Med (1999) 1.95
[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab (1999) 1.90
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer. Cancer Res (2000) 1.85
[3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors. Proc Natl Acad Sci U S A (1986) 1.85
Quantitative imaging of iodine-124 with PET. J Nucl Med (1996) 1.69
Radioimmunotherapy with alpha-emitting nuclides. Eur J Nucl Med (1998) 1.67
Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1993) 1.60
A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine. Mol Pharmacol (1986) 1.55
Probing the adenosine receptor with adenosine and xanthine biotin conjugates. FEBS Lett (1985) 1.52
Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature (1984) 1.50
Failure to activate the left temporoparietal cortex in dyslexia. An oxygen 15 positron emission tomographic study. Arch Neurol (1992) 1.48
Molecular probes for extracellular adenosine receptors. Biochem Pharmacol (1987) 1.47
Inhibition of NO synthesis in septic shock. Lancet (1992) 1.46
Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours. Clin Endocrinol (Oxf) (1999) 1.45
A double FDG/PET study of the effects of scopolamine in older adults. Neuropsychopharmacology (1994) 1.44
Enhanced prostanoid-mediated vasorelaxation in pulmonary arteries isolated during experimental endotoxemia. Shock (1999) 1.42
Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry. J Nucl Med (1999) 1.42
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. J Clin Oncol (1991) 1.42
Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors. FEBS Lett (1986) 1.42
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol (1994) 1.41
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg (1999) 1.41
Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci (1986) 1.39
Effort and cognition in depression. Arch Gen Psychiatry (1982) 1.37
The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man. Can J Neurol Sci (1984) 1.36
Syntaxin 1A inhibits CFTR chloride channels by means of domain-specific protein-protein interactions. Proc Natl Acad Sci U S A (1998) 1.35
Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. J Clin Oncol (1993) 1.35
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum (2000) 1.32
Studies on the pathogenesis of plague. Blood coagulation and tissue responses of Macaca mulatta following exposure to aerosols of Pasteurella pestis. Am J Pathol (1968) 1.29
DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci (1998) 1.29
Development of fluorine-18-labeled 5-HT1A antagonists. J Med Chem (1999) 1.27
Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology (1989) 1.23
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol (1996) 1.21
Hemoglobin Richmond, a human hemoglobin which forms asymmetric hybrids with other hemoglobins. J Biol Chem (1969) 1.20
PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635. Nucl Med Biol (2000) 1.20
Possible development of the serotonin syndrome in man. Am J Psychiatry (1982) 1.17
A [3H]amine congener of 1,3-dipropyl-8-phenylxanthine. A new radioligand for A2 adenosine receptors of human platelets. FEBS Lett (1986) 1.16
Syntaxin 1A is expressed in airway epithelial cells, where it modulates CFTR Cl(-) currents. J Clin Invest (2000) 1.16
A novel 8-phenyl-substituted xanthine derivative is a selective antagonist at adenosine A1-receptors in vivo. Acta Physiol Scand (1985) 1.16
Interleukin 3 stimulates proliferation via protein kinase C activation without increasing inositol lipid turnover. Proc Natl Acad Sci U S A (1988) 1.16
Cytidine deaminase from Escherichia coli. Purification, properties and inhibition by the potential transition state analog 3,4,5,6-tetrahydrouridine. J Biol Chem (1971) 1.14
Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res (1993) 1.13
Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. J Am Coll Cardiol (1993) 1.13
Basolateral potassium channel in turtle colon. Evidence for single-file ion flow. J Gen Physiol (1983) 1.12
Cell cycle dependence of chloride permeability in normal and cystic fibrosis lymphocytes. Science (1990) 1.11
The heterogeneity of goat hemoglobin: evidence for the existence of two nonallelic and one allelic alpha chain structural genes. Arch Biochem Biophys (1967) 1.11
High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry (1999) 1.11
Active sodium transport by turtle colon via an electrogenic Na-K exchange pump. Nature (1980) 1.10
8-Substituted xanthines as antagonists at A1- and A2-adenosine receptors. Biochem Pharmacol (1988) 1.10
Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study. Arch Gen Psychiatry (1987) 1.10
Following up endogenous nitric oxide article. J Am Vet Med Assoc (1997) 1.10
Plasma catecholamine concentrations in unanesthetized rats during sleep, wakefulness, immobilization and after decapitation. J Pharmacol Exp Ther (1977) 1.10
PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma. J Nucl Med (1992) 1.10
Drugs and the heart muscle. J Am Vet Med Assoc (1977) 1.10
Positron-emission tomography and personality disorders. Neuropsychopharmacology (1994) 1.09
Adenovirus-mediated p21((WAF1/SDII/CIP1)) gene transfer induces apoptosis of human cervical cancer cell lines. J Virol (1999) 1.09
Accumulation of vitamin C (ascorbate) and its oxidized metabolite dehydroascorbic acid occurs by separate mechanisms. J Biol Chem (1995) 1.08
Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med (1988) 1.08
Workplace smoking related absenteeism and productivity costs in Taiwan. Tob Control (2005) 1.08
Cognitive processes in depression. Arch Gen Psychiatry (1981) 1.08
High-dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry (1994) 1.08
Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Arch Gen Psychiatry (1990) 1.07
A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies. Nucl Med Biol (1995) 1.07
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. Clin Cancer Res (1998) 1.07
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol (1994) 1.06
Low medial prefrontal dopaminergic activity in autistic children. Lancet (1997) 1.06
Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry (1983) 1.05
Variable deterioration in cortical function during insulin-induced hypoglycemia. Diabetes (1985) 1.05
Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review. Am J Kidney Dis (1994) 1.05
Benzodiazepine receptor-mediated experimental "anxiety" in primates. Science (1982) 1.05
Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J (2009) 1.05
Fusarium polycaprolactone depolymerase is cutinase. Appl Environ Microbiol (1996) 1.04
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity. Blood (1994) 1.03
Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. Nucl Med Biol (1996) 1.03
Activation of DeltaF508 CFTR in an epithelial monolayer. Am J Physiol (1998) 1.03
Hemoglobin C in newborn sheep and goats: a possible explanation for its function and biosynthesis. Pediatr Res (1969) 1.03
Gender-related differences in regional cerebral glucose metabolism in normal volunteers. Psychiatry Res (1994) 1.03
18F-labeled insulin: a prosthetic group methodology for incorporation of a positron emitter into peptides and proteins. Biochemistry (1989) 1.03
Distinct functional properties of Rab3A and Rab3B in PC12 neuroendocrine cells. J Biol Chem (1996) 1.03
N6-functionalized congeners of adenosine with high potency at A2-adenosine receptors: potential ligands for affinity chromatography. Biochem Biophys Res Commun (1986) 1.02
Contrast media-associated nephrotoxicity. Semin Nephrol (1997) 1.01
Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals. Brain Res (1985) 1.01
Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation (1990) 1.01
Minimally invasive surgery: video endoscopic thoracic sympathectomy for palmar hyperhidrosis. Ann Acad Med Singapore (1996) 1.01